Loading insider details...
Latest Form 4 (Oct 16, 2026): Grant/Award of 153 GRAL shares, $20.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 16, 2026 | GRAIL, Inc. (GRAL) | Grant/Award | 153 | $20.7K |
| Jul 16, 2026 | GRAIL, Inc. (GRAL) | Grant/Award | 276 | $20.5K |
| Jun 22, 2026 | GRAIL, Inc. (GRAL) | Grant/Award | 5,491 | $350.0K |
| Jun 10, 2026 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 9,200 | n/a |
| Apr 17, 2026 | GRAIL, Inc. (GRAL) | Grant/Award | 408 | $20.3K |
| Jan 16, 2026 | GRAIL, Inc. (GRAL) | Grant/Award | 213 | $20.8K |
| Oct 16, 2025 | GRAIL, Inc. (GRAL) | Grant/Award | 275 | $20.8K |
| Aug 22, 2025 | Intellia Therapeutics, Inc. (NTLA) | Purchase | 100,000 | $1.00M |
| Jul 17, 2025 | GRAIL, Inc. (GRAL) | Grant/Award | 533 | $20.5K |
| Jun 13, 2025 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 8,000 | n/a |